← back to search

Thomas Wolff

University Hospital of Basel · CH
🔎 Find collaborators in Organic Chemistry · Physical and Theoretical Chemistry →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Organic Chemistry · Physical and Theoretical Chemistry
Research interest
Research interests include Surfactants and Colloidal Systems, Photochemistry and Electron Transfer Studies, Spectroscopy and Quantum Chemical Studies, and Organ Donation and Transplantation.
h-index
38
citations
5,800
works
350
NIH funding
primary concept
Medicine
email

Recent publications

Single-kidney transplantation with discarded partner kidney vs. Dual kidney transplantation: results from a national cohort study.
2026cited by 0position: contributordoi
Long-Term Efficacy and Safety of Luspatercept for Anemia Treatment in Patients With Lower-Risk Myelodysplastic Syndromes: The Phase II PACE-MDS Study
Journal of Clinical Oncology 2022cited by 34position: middledoi
Robust Angiogenesis and Arteriogenesis in the Skin of Diabetic Mice by Transient Delivery of Engineered VEGF and PDGF-BB Proteins in Fibrin Hydrogels
Frontiers in Bioengineering and Biotechnology 2021cited by 40position: middledoi
Stent Design, Restenosis and Recurrent Stroke After Carotid Artery Stenting in the International Carotid Stenting Study
Stroke 2019cited by 58position: middledoi
PACIFIC subgroup analysis: pneumonitis in stage III, unresectable NSCLC patients treated with durvalumab vs. placebo after CRT
Pneumologie 2019cited by 12position: middledoi
Restenosis and risk of stroke after stenting or endarterectomy for symptomatic carotid stenosis in the International Carotid Stenting Study (ICSS): secondary analysis of a randomised trial
The Lancet Neurology 2018cited by 177position: middledoi
PACIFIC: eine doppelblinde, Placebo-kontrollierte Phase-III-Studie zu Durvalumab als Konsolidierungstherapie nach einer Strahlenchemotherapie bei Patienten mit lokal fortgeschrittenem, inoperablem NSCLC
Pneumologie 2018cited by 0position: middledoi
Luspatercept for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes (PACE-MDS): a multicentre, open-label phase 2 dose-finding study with long-term extension study
The Lancet Oncology 2017cited by 287position: middledoi
Luspatercept Increases Hemoglobin and Reduces Transfusion Burden in Patients with Low-Intermediate Risk Myelodysplastic Syndromes (MDS): Long-Term Results from Phase 2 PACE-MDS Study
Blood 2016cited by 15position: middledoi
Extracellular Matrix and Growth Factor Engineering for Controlled Angiogenesis in Regenerative Medicine
Frontiers in Bioengineering and Biotechnology 2015cited by 185position: middledoi
Luspatercept Treatment Leads to Long Term Increases in Hemoglobin and Reductions in Transfusion Burden in Patients with Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS): Preliminary Results from the Phase 2 PACE-MDS Extension Study
Blood 2015cited by 27position: middledoi
53 LUSPATERCEPT INCREASES HEMOGLOBIN AND REDUCES TRANSFUSION BURDEN IN PATIENTS WITH LOW OR INTERMEDIATE-1 RISK MYELODYSPLASTIC SYNDROMES (MDS): PRELIMINARY RESULTS FROM A PHASE 2 STUDY
Leukemia Research 2015cited by 20position: middledoi
ACE-536 Increases Hemoglobin and Reduces Transfusion Burden in Patients with Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS): Preliminary Results from a Phase 2 Study
Blood 2014cited by 12position: middledoi

Grants

CPATH CB: Computing and Undergraduate Engineering: A Collaborative Process to Align Computing Education with Engineering Workforce Needs
NSF0722221$489,8592007–2010PIRePORTER
Mathematical Sciences: Harmonic Analysis and the Laplace Equation
NSF9307872$180,0001993–1996PIRePORTER
Mathematical Sciences: Potential Theory in n-space
NSF8914039$41,9841989–1990PIRePORTER
Mathematical Sciences: Potential Theory in n-space
NSF8703456$94,2641987–1989PIRePORTER
Mathematical Sciences Postdoctoral Research Fellowship
NSF8017153$39,0001980–1982PIRePORTER

Frequent collaborators

Uwe Platzbecker · University College London6 papers (2014–2022)Karin Mayer · Heinrich Heine University Düsseldorf6 papers (2014–2022)Markus P. Radsak · Johannes Gutenberg University Mainz6 papers (2014–2022)Philipp Kiewe · Charité - Universitätsmedizin Berlin6 papers (2014–2022)Aristoteles Giagounidis · Marien Hospital Düsseldorf6 papers (2014–2022)Ulrich Germing · Bristol-Myers Squibb (Switzerland)5 papers (2014–2022)Kenneth M. Attie · Huntsman Cancer Institute5 papers (2014–2022)Katharina S. Götze · German Cancer Research Center4 papers (2015–2022) · 4 papers (2015–2022)Matthew L. Sherman · Deciphera Pharmaceuticals (United States)4 papers (2014–2017)Dawn Wilson · Huntsman Cancer Institute4 papers (2014–2016)Abderrahmane Laadem · Daiichi Sankyo (United States)3 papers (2015–2017)Detlef Haase · University of Mannheim3 papers (2014–2022)Martin Reck · St. Luke's Clinic2 papers (2018–2019) · 2 papers (2015–2021)Oliver G. Ottmann · Cancer Genetics (United States)2 papers (2015–2015)Christian Schulz · University of Regensburg2 papers (2018–2019)Jöerg Chromik · Goethe University Frankfurt2 papers (2016–2022) · 2 papers (2014–2015) · 2 papers (2018–2019)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Organic Chemistry · Physical and Theoretical Chemistry →